论文部分内容阅读
目的:探讨米非司酮治疗绝经期功能失调性子宫出血的疗效。方法:选取我院2008年2月至2009年2月收治的38例确诊为功血患者。给予患者每天服用一次米非司酮,服用量为10毫克,服用时间为每天睡觉前,空腹服用,疗程为四个月。在治疗前和治疗之后第2、4个月,对比分析患者的治疗效果,进行血常规检查、肝肾功能检查和子宫内膜厚度检查。结果:38例功血患者在服用药物期间,子宫内膜厚度改变显著,所有患者的血红蛋白水平呈现不同程度的提高,肝肾功能正常,贫血现象也明显好转。治疗前后比较,具有显著差异(P<0.05)。结论:米非司酮对功血患者具有明显的临床效果,且不良反应少,复发率低。
Objective: To investigate the efficacy of mifepristone in treating dysfunctional uterine bleeding in menopause. Methods: 38 cases diagnosed as dysfunctional uterine bleeding in our hospital from February 2008 to February 2009 were selected. Patients given mifepristone once daily intake of 10 mg, taking time for each day before going to bed, take an empty stomach, treatment for four months. Before treatment and after treatment for the first two months, comparative analysis of the patient’s treatment, blood tests, liver and kidney function tests and endometrial thickness examination. Results: Thirty-eight patients with dysfunctional uterine bleeding had significant changes in endometrial thickness during medication. All patients showed hemoglobin levels increased to varying degrees, with normal liver and kidney function and markedly improved anemia. Before and after treatment, there was a significant difference (P <0.05). Conclusion: Mifepristone has obvious clinical effect on patients with dysfunctional uterine bleeding, with less adverse reactions and low recurrence rate.